QOF · 2026/27

QOF — Quality & Outcomes Framework 2026/27

Last update

22 July 2026

Data source

Clinical system

Refresh

Weekly · live

Next refresh

Auto · weekly

Indicator type

Date window

PCN & Practice

View as at

KPIs on target

1/39

38 below · 6 monitoring

Performance

42.3%

36 payment KPIs

Highest performing

VI004

85.5% · target 50–60% · +25.5%

473 / 553

Lowest performing

DM006

4.7% · target 57–97% · -92.3%

131 / 2,775

Most improved

—

Needs 2+ uploads

On target (1)Near target (6)Below target (30)No data (8)Mon= Monitoring only — no payment threshold

Indicator⇅	Target⇅	Target activity⇅	Performance %⇅	Activity⇅	Population⇅	Shortfall⇅	Status
Respiratory
AST007Asthma with review in last 12 months▸	45–70%	8,710	33%	4,112	12,442	4,598	Below
AST008Asthma aged 19 or under with smoking status or exposureMon▸	Monitoring	—	35.4%	716	2,020	—	Monitoring
AST012Asthma with objective tests recorded▸	45–80%	210	57.3%	150	262	60	Below
COPD010COPD with review including exacerbations, breathlessness▸	50–90%	3,169	27.1%	953	3,521	2,216	Below
COPD014COPD and MRC >=3 and offered pulmonary rehabilitationMon▸	Monitoring	—	65.2%	131	201	—	Monitoring
Cardiovascular
AF006Patients with AF and CHA2DS2-VASc score▸	40–95%	643	55.6%	376	676	267	Below
AF008Patients with AF and a CHA2DS2-VASc score>=2 on DOAC /Vit K antagonist▸	70–95%	1,544	3.8%	62	1,625	1,482	Below
BP002Patients aged 45 or over and blood pressure recorded▸	50–90%	86,283	87.5%	83,846	95,870	2,437	Near
CHD005CHD taking anti-platelet or anti-coagulant▸	56–96%	5,924	86.3%	5,325	6,170	599	Near
CHOL003Patients with CHD / PAD / TIA / CKD on statin/lipid-lowering therapy▸	70–95%	7,805	4.6%	380	8,215	7,425	Below
CHOL004Patients with LDL cholesterol <=2.0 or non-HDL <=2.6▸	20–50%	4,335	25%	2,169	8,670	2,166	Below
HF007Heart failure with review of functional capacity, medication▸	50–90%	1,571	11%	192	1,745	1,379	Below
HF008Heart failure diagnosis from 1 April 2023 with ECHO or specialist assess▸	50–90%	656	83.8%	610	728	46	Near
HYP008Hypertension aged 79 or under BP 140/90 mmHg or less▸	40–85%	21,526	39.9%	11,160	27,955	10,366	Below
HYP009Hypertension aged 80 or over BP 150/90 mmHg or less▸	40–85%	2,884	44.1%	1,589	3,604	1,295	Below
STIA007Non-haemorrhagic stroke or TIA taking anti-platelet or anti-coagulant▸	57–97%	1,712	84.3%	1,487	1,764	225	Near
Cancer
CAN004Cancer care review within 12 monthsMon▸	Monitoring	—	34.1%	157	460	—	Monitoring
CAN005Cancer support offered within 3 monthsMon▸	Monitoring	—	26.3%	140	533	—	Monitoring
Dementia
DEM004Dementia and review done▸	35–70%	759	16.3%	177	1,084	582	Below
Other
DEPCC01Patients aged 18 or over with a new diagnosis of depression▸	NIS	—	—	2,481	—	—	No data
Mental Health
DEP004New diagnosis of depression with a review doneMon▸	Monitoring	—	13.1%	263	2,006	—	Monitoring
MH002Mental health and care plan documented▸	40–90%	4,047	19.9%	895	4,496	3,152	Below
MH003Mental health problems and BP recorded in the preceding 12 months▸	50–90%	4,111	41.6%	1,901	4,567	2,210	Below
MH006Mental health problems and BMI recorded in the preceding 12 months▸	50–90%	4,108	37.9%	1,729	4,564	2,379	Below
MH007Mental health problems and alcohol recorded in last 12 months▸	50–90%	4,107	36.6%	1,671	4,563	2,436	Below
MH011Mental health problems and lipids recorded in last 12 months▸	50–90%	4,109	40.2%	1,835	4,565	2,274	Below
MH012Mental health problems and glucose/Hba1c recorded in last 12 months▸	NIS	—	—	1,052	—	—	No data
MH021Mental health problems and all 6 elements of physical health check▸	80%	3,801	24.3%	1,153	4,751	2,648	Below
Diabetes
DM006Diabetes and proteinuria or micro-albuminuria taking ACE-I or ARB▸	57–97%	2,692	4.7%	131	2,775	2,561	Below
DM014Newly diagnosed with diabetes referred to structured education programme▸	40–90%	582	41.3%	267	646	315	Below
DM020Diabetes no moderate/severe frailty IFCC-HbA1c is 58 mmol/mol or less▸	35–75%	16,308	26.9%	5,842	21,743	10,466	Below
DM021Diabetes with frailty IFCC-HbA1c is 75 mmol/mol or less▸	NIS	—	—	1,020	—	—	No data
DM034Diabetes aged >=40 no CVD/frailty on statin or lipid-lowering therapy▸	50–90%	11,310	4.8%	601	12,566	10,709	Below
DM035Diabetes with CVD (not haemorrhagic) on statin or lipid-lowering therapy▸	50–90%	5,716	5.4%	341	6,351	5,375	Below
DM036Diabetes no moderate/severe frailty BP 140/90 mmHg or less▸	38–90%	20,370	45.4%	9,526	20,999	10,844	Below
NDH002Non-diabetic hyperglycaemia with HbA1c or fasting glucose▸	50–90%	9,520	36.4%	5,418	14,875	4,102	Below
Vaccination & Immunisation
VI001Three or more DTaP vaccine doses before 8 months▸	89–96%	3,555	55%	2,035	3,703	1,520	Below
VI002One or more MMR doses aged 12-18 months▸	86–96%	3,834	12.9%	516	3,993	3,318	Below
VI003Aged 1-5 years with DTaP/IPV booster and at least 2 doses of MMR▸	81–96%	3,433	67.4%	2,411	3,576	1,022	Below
VI004Aged 80 with shingles vaccine received between 70-79 years▸	50–60%	332	85.5%	473	553	Met	Met
Cervical Screening
CS005Aged 25-49 adequate smear last 3 years and 6 months▸	45–80%	66,048	51.8%	42,745	82,559	23,303	Below
CS006Aged 50-64 adequate smear last 5 years and 6 months▸	45–80%	14,121	75.7%	13,368	17,651	753	Near
Smoking
SMOK002Chronic disease and smoking status recorded▸	50–90%	52,800	81.9%	48,062	58,666	4,738	Near
SMOK004Current smokers with an offer of support given▸	40–90%	42,301	69%	32,444	47,001	9,857	Below
SMOK005Chronic disease and smoking advice givenMon▸	96%	9,210	52.3%	5,020	9,593	4,190	Below

Data as of 22 July 2026 · Clinical system · Refreshed weekly